Updated European Consensus Statement on diagnosis and treatment of adult ADHD

Autor: K. Foeken, Florina Rad, Asko Niemelä, S. Young, Julio Bobes, Stefano Pallanti, Luana Salerno, S. Markovska Simoska, Judit Balazs, V. Richarte, E. Sobanski, Bengi Semerci, Ylva Ginsberg, T. Lehtonen, Josep Antoni Ramos-Quiroga, P. Brudkiewicz, N. Motavalli Mukaddes, T. Saito, D. Baeyens, Jane McCarthy, István Bitter, C. Nunes Filipe, Sami Leppämäki, Artemios Pehlivanidis, Pekka Tani, P. Asherson, Martin D. Ohlmeier, A. Kjems Philipsen, Johanna Krause, Richard Delorme, B. Styr, Z. Félegyházy, Michael Fitzgerald, J.J.S. Kooij, Michael B. Lensing, Ilinca Mihailescu, M.P. García-Portilla, V. Pironti, Susanne Bejerot, Blanca Bolea-Alamanac, Pieter-Jan Carpentier, D. Edvinsson, U. Müller-Sedgwick, Fiona McNicholas, James Kustow, Alexandra Philipsen, Johannes Thome, Michael Gill, Hervé Caci, Iris Manor, S. Stes, John Fayyad, Denise Bijlenga, R. Jaeschke, Marios Adamou, Geert Dom, Pavel Mohr, Peik Gustafsson, Iuliana Dobrescu, Miguel Casas, P. De Rossi, P. Oswald, Dora Wynchank, Siegfried Kasper, Tatja Hirvikoski
Přispěvatelé: Department of Psychiatry, Clinicum, University of Helsinki, HUS Psychiatry, HKÜ, Sağlık Bilimleri Fakültesi, Psikoloji Bölümü, Psychiatry, APH - Mental Health, VU University medical center, APH - Health Behaviors & Chronic Diseases
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
MENTAL-HEALTH-SERVICES
medicine.medical_treatment
Adult ADHD
Updated European Consensus Statement
Diagnosis
Treatment
European Network Adult ADHD
EPA
SERIOUS CARDIOVASCULAR EVENTS
MEDICATION-TREATED ADULTS
GUANFACINE EXTENDED-RELEASE
Health Services Accessibility
3124 Neurology and psychiatry
law.invention
0302 clinical medicine
Randomized controlled trial
law
Prevalence
Psychology
COGNITIVE-BEHAVIORAL THERAPY
Borderline personality disorder
Psychiatry
BORDERLINE PERSONALITY-DISORDER
RANDOMIZED CONTROLLED-TRIAL
3. Good health
ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER
Europe
Substance abuse
Cognitive behavioral therapy
Psychiatry and Mental health
Practice Guidelines as Topic
Female
Adult
medicine.medical_specialty
Consensus
MEDLINE
behavioral disciplines and activities
Psykiatri
03 medical and health sciences
mental disorders
medicine
Humans
Attention deficit hyperactivity disorder
DEFICIT-HYPERACTIVITY-DISORDER
business.industry
medicine.disease
Mental health
030227 psychiatry
Psychotherapy
Attention Deficit Disorder with Hyperactivity
Diagnostic assessment
Central Nervous System Stimulants
SUBSTANCE USE DISORDER
Human medicine
business
030217 neurology & neurosurgery
Zdroj: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
WOS:000458502900003
European psychiatry
Kooij, J J S, Bijlenga, D, Salerno, L, Jaeschke, R, Bitter, I, Balázs, J, Thome, J, Dom, G, Kasper, S, Nunes Filipe, C, Stes, S, Mohr, P, Leppämäki, S, Casas Brugué, M, Bobes, J, Mccarthy, J M, Richarte, V, Kjems Philipsen, A, Pehlivanidis, A, Niemela, A, Styr, B, Semerci, B, Bolea-Alamanac, B, Edvinsson, D, Baeyens, D, Wynchank, D, Sobanski, E, Philipsen, A, McNicholas, F, Caci, H, Mihailescu, I, Manor, I, Dobrescu, I, Krause, J, Fayyad, J, Ramos-Quiroga, J A, Foeken, K, Rad, F, Adamou, M, Ohlmeier, M, Fitzgerald, M, Gill, M, Lensing, M, Motavalli Mukaddes, N, Brudkiewicz, P, Gustafsson, P, Tani, P, Oswald, P, Carpentier, P J, de Rossi, P, Delorme, R, Markovska Simoska, S, Pallanti, S, Young, S, Bejerot, S, Lehtonen, T, Kustow, J, Müller-Sedgwick, U, Hirvikoski, T, Pironti, V, Ginsberg, Y, Félegeházy, Z, Garcia-Portilla, M P & Asherson, P 2019, ' Updated European Consensus Statement on diagnosis and treatment of adult ADHD ', European Psychiatry, vol. 56, pp. 14-34 . https://doi.org/10.1016/j.eurpsy.2018.11.001
European Psychiatry, 56, 14-34. Elsevier Masson
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2018.11.001
Popis: Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness.Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated.Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated?Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.
Databáze: OpenAIRE